172 related articles for article (PubMed ID: 33024108)
1. A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression.
Kim H; Cho Y; Kim HS; Kang D; Cheon D; Kim YJ; Chang MJ; Lee KM; Chang CB; Kang SB; Kang HG; Kim JH
Nat Commun; 2020 Oct; 11(1):5023. PubMed ID: 33024108
[TBL] [Abstract][Full Text] [Related]
2. CORR Insights®: Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?
Ramsey DC
Clin Orthop Relat Res; 2024 Jun; 482(6):957-959. PubMed ID: 38446419
[No Abstract] [Full Text] [Related]
3. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma.
Rey V; Tornín J; Alba-Linares JJ; Robledo C; Murillo D; Rodríguez A; Gallego B; Huergo C; Viera C; Braña A; Astudillo A; Heymann D; Szuhai K; Bovée JVMG; Fernández AF; Fraga MF; Alonso J; Rodríguez R
EBioMedicine; 2024 Apr; 102():105090. PubMed ID: 38547578
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma.
Skipar P; Dey M; Piątkowski J; Sulejczak D; Rutkowski P; Czarnecka AM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542153
[TBL] [Abstract][Full Text] [Related]
5. HIF-2α is indispensable for regulatory T cell function.
Hsu TS; Lin YL; Wang YA; Mo ST; Chi PY; Lai AC; Pan HY; Chang YJ; Lai MZ
Nat Commun; 2020 Oct; 11(1):5005. PubMed ID: 33024109
[TBL] [Abstract][Full Text] [Related]
6. p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability.
Wu L; Crawley CD; Garofalo A; Nichols JW; Campbell PA; Khramtsova GF; Olopade OI; Weichselbaum RR; Yamini B
Nat Commun; 2020 Oct; 11(1):5007. PubMed ID: 33024116
[TBL] [Abstract][Full Text] [Related]
7. METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.
Wu Z; Shi Y; Lu M; Song M; Yu Z; Wang J; Wang S; Ren J; Yang YG; Liu GH; Zhang W; Ci W; Qu J
Nucleic Acids Res; 2020 Nov; 48(19):11083-11096. PubMed ID: 33035345
[TBL] [Abstract][Full Text] [Related]
8. Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and
Perez RE; Calhoun S; Shim D; Levenson VV; Duan L; Maki CG
Cancer Biol Ther; 2020 Nov; 21(11):1033-1040. PubMed ID: 33044914
[TBL] [Abstract][Full Text] [Related]
9. The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress.
Bauer M; Nascakova Z; Mihai AI; Cheng PF; Levesque MP; Lampart S; Hurwitz R; Pfannkuch L; Dobrovolna J; Jacobs M; Bartfeld S; Dohlman A; Shen X; Gall AA; Salama NR; Töpfer A; Weber A; Meyer TF; Janscak P; Müller A
Nat Commun; 2020 Oct; 11(1):5117. PubMed ID: 33037203
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics.
Lyu J; Yang EJ; Zhang B; Wu C; Pardeshi L; Shi C; Mou PK; Liu Y; Tan K; Shim JS
Nat Commun; 2020 Oct; 11(1):5105. PubMed ID: 33037191
[TBL] [Abstract][Full Text] [Related]
11. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells.
Wang J; Liu X; Zheng H; Liu Q; Zhang H; Wang X; Shen T; Wang S; Ren D
Chem Biol Interact; 2020 Nov; 331():109279. PubMed ID: 33035517
[TBL] [Abstract][Full Text] [Related]
12. Identification of a dynamic gene regulatory network required for pluripotency factor-induced reprogramming of mouse fibroblasts and hepatocytes.
Papathanasiou M; Tsiftsoglou SA; Polyzos AP; Papadopoulou D; Valakos D; Klagkou E; Karagianni P; Pliatska M; Talianidis I; Agelopoulos M; Thanos D
EMBO J; 2021 Jan; 40(1):e102236. PubMed ID: 33034061
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA prevents LPS-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages.
Liu QY; Zhuang Y; Song XR; Niu Q; Sun QS; Li XN; Li N; Liu BL; Huang F; Qiu ZX
Acta Pharmacol Sin; 2021 Jun; 42(6):987-997. PubMed ID: 33028985
[TBL] [Abstract][Full Text] [Related]
14. Framework for quality assessment of whole genome cancer sequences.
Whalley JP; Buchhalter I; Rheinbay E; Raine KM; Stobbe MD; Kleinheinz K; Werner J; Beltran S; Gut M; Hübschmann D; Hutter B; Livitz D; Perry MD; Rosenberg M; Saksena G; Trotta JR; Eils R; Gerhard DS; Campbell PJ; Schlesner M; Gut IG
Nat Commun; 2020 Oct; 11(1):5040. PubMed ID: 33028839
[TBL] [Abstract][Full Text] [Related]
15. TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment.
Le BV; Podszywalow-Bartnicka P; Maifrede S; Sullivan-Reed K; Nieborowska-Skorska M; Golovine K; Yao JC; Nejati R; Cai KQ; Caruso LB; Swatler J; Dabrowski M; Lian Z; Valent P; Paietta EM; Levine RL; Fernandez HF; Tallman MS; Litzow MR; Huang J; Challen GA; Link D; Tempera I; Wasik MA; Piwocka K; Skorski T
Cell Rep; 2020 Oct; 33(1):108221. PubMed ID: 33027668
[TBL] [Abstract][Full Text] [Related]
16. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis.
Huang YL; Liang CY; Ritz D; Coelho R; Septiadi D; Estermann M; Cumin C; Rimmer N; Schötzau A; Núñez López M; Fedier A; Konantz M; Vlajnic T; Calabrese D; Lengerke C; David L; Rothen-Rutishauser B; Jacob F; Heinzelmann-Schwarz V
Elife; 2020 Oct; 9():. PubMed ID: 33026975
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis.
Chen F; Gao Q; Wei A; Chen X; Shi Y; Wang H; Cao W
Cell Death Differ; 2021 Mar; 28(3):1001-1012. PubMed ID: 33024274
[TBL] [Abstract][Full Text] [Related]
18. 2-Oxoglutarate-dependent dioxygenases in cancer.
Losman JA; Koivunen P; Kaelin WG
Nat Rev Cancer; 2020 Dec; 20(12):710-726. PubMed ID: 33087883
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.
Si W; Zhou B; Xie W; Li H; Li K; Li S; Deng W; Shi P; Yuan C; Ke T; Ren X; Tu X; Zeng X; Weigelt B; Rubin BP; Chen Q; Xu C; Wang QK
Cancer Lett; 2021 Jan; 497():28-40. PubMed ID: 33069768
[TBL] [Abstract][Full Text] [Related]
20. BNIP3L/Nix-induced mitochondrial fission, mitophagy, and impaired myocyte glucose uptake are abrogated by PRKA/PKA phosphorylation.
da Silva Rosa SC; Martens MD; Field JT; Nguyen L; Kereliuk SM; Hai Y; Chapman D; Diehl-Jones W; Aliani M; West AR; Thliveris J; Ghavami S; Rampitsch C; Dolinsky VW; Gordon JW
Autophagy; 2021 Sep; 17(9):2257-2272. PubMed ID: 33044904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]